| Filed On | Filing |
|---|---|
| 07 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events
New operating structure designed to increase efficiency and support continued growth |
| 23 Sep 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On September 21, 2026, Arthur C. Butcher informed Boston Scientific Corporation (the “Company”) that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January... |
| 08 Sep 2026 |
8-K: <ITEMS>1.05
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission. |
| 03 Sep 2026 |
Form 4: O'Connor Padraig Andrew, EVP, Global Operations
Received 1,171 shares by exercise or conversion · Gave up 567 shares to cover exercise price or tax ($27.4K) |
| 26 Aug 2026 |
Form 4: Morano Susan E, Director
Bought 2,040 shares ($100K) |
| 26 Aug 2026 | 8-K: Other Events |
| 12 Aug 2026 |
Form 4: Woodworth Emily, SVP, Global Controller and CAO
Acquired 2,930 shares (Discretionary Transaction) ($150K) |
| 11 Aug 2026 |
Form 4: Monson Jonathan, EVP and CFO
Acquired 9,908 shares (Discretionary Transaction) ($500K) |
| 07 Aug 2026 |
Form 4: Habiger David C, Director
Bought 2,100 shares ($99.9K) |
| 06 Aug 2026 | SCHEDULE 13G/A |
| 05 Aug 2026 |
Form 4: Habiger David C, Director
Bought 1,042 shares ($50.1K) · Bought 140 shares ($6.8K) |
| 05 Aug 2026 |
Form 4: Mahoney Michael F, Director
Bought 186,240 shares ($9M) · Acquired 22,119 shares (Discretionary Transaction) ($1.07M) |
| 03 Aug 2026 |
Form 4: Ludwig Edward J, Director
Bought 5,000 shares ($227K) |
| 03 Aug 2026 |
Form 4: Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology
Acquired 64,198 shares (Discretionary Transaction) ($3M) |
| 03 Aug 2026 | 10-Q |
| 29 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 27 Jul 2026 | 8-K: Costs Associated with Exit or Disposal Activities |
| 02 Jul 2026 |
Form 4: Monson Jonathan, EVP and CFO
Received 2,087 shares by exercise or conversion · Gave up 1,010 shares to cover exercise price or tax ($43.5K) |
| 24 Jun 2026 | 11-K |
| 01 Jun 2026 |
Form 4: Mahoney Michael F, Director
Gave 386,755 shares as a gift |
Loading...
